Quture International, Inc. Establishes Company's Innovation and Technology Center Headquartered in Daytona Beach, Florida05/09/2012 | Press Release
DAYTONA BEACH, FL - Quture International, Inc. (TCLN.PK) (TCLN.PK) and its operations subsidiary Quture, Inc. ("Quture"), an emerging growth company positioned to become the leading clinical knowledge company in the world, opened the doors to the company's Innovation and Technology Center on May 7, 2012. The new 4,045 square foot Center is located at 200 Magnolia Avenue in Daytona Beach, Florida and sits on a 24,750 square foot corner lot.
"As our partners and employees have come to learn, we thrive on providing a professional working environment with the latest in high-tech communications and business solutions in a comfortable setting enriched by surrounding entertainment options for Quture's upscale client demographic," said Landon Feazell, Chairman and CEO of Quture International, Inc. "The spectacular historic building chosen for our new headquarters is centrally located in Daytona's business district. As an agile company which values collaboration, creativity, and being ahead of the technology curve, we wanted to find the perfect location to become an extension of those values."
Quture's Innovation and Technology Center is within walking distance to Beach Street shops, restaurants, Halifax River, the Halifax Marina and Yacht Club and the Jackie Robinson Stadium. The new location is a historic brick building built in 1935, fully renovated boasting 10 private offices, a central conference room wholly equipped with audio visual equipment to host national and international meetings, a medical research library and amenities for the employees and guests, including ample parking, a center courtyard and breakout areas. Additionally, Quture's high-tech business solutions support eco-friendly efforts for transitioning to a paperless work environment.
"As Quture moves dramatically to implement our business plan and vision statement, we enjoy a 'jump the curve' and 'blue ocean' strategic opportunity unparalleled in the healthcare analytics market internationally. The new Center positions our Innovations and Technology Teams to add key leadership and support staff," said Feazell.
Additional office openings and other significant developments are anticipated throughout 2012 and beyond.
QUTURE INTERNATIONAL, INC.
Quture International, Inc. is an emerging growth company positioned to become the leading clinical knowledge company in the world. The core competence of Quture is clinical performance enhancement to achieve optimal clinical patient outcomes. Q's brand is centered on the value proposition of trust, transparency and independence. As the free enterprise solution to improving health and health care while reducing costs, Quture is comprised of subsidiaries for operations of its software technology solutions, a "beyond data" consulting and knowledge applications company, and a personalized, proactive, and predictive medicine company with a virtual community of members. These subsidiaries are all affiliated with the Qx Medical Exchange which will become the largest medical and health exchange in the world. Quture International is a Nevada corporation currently trading under the symbol TCLN.
Quture, Inc. is the operations subsidiary of Quture International, Inc., positioned to become the international standard in health care performance, outcomes and analytics. Q's transformational product QualOptima operates on the InterSystems technology platform, the leading software platform globally for health care. QualOptima is the transcendent healthcare analytics system for performance enhancement to achieve optimal patient outcomes, measuring against evidence-based clinical processes of care. The clinical data repository of QualOptima, the Qualytx integrated aggregate clinical database, is planned to become the common data platform for health and health care. Qualytx will then be capable of transforming personal health and health care through knowledge solutions founded in Q's proprietary science of knowing what to measure, where that data resides in disparate databases and imposing its revolutionary and proprietary technology to electronically abstract that data. As America transitions to payment for value and U.S. and international pressures converge to measure performance, Quture will navigate the future of global health and healthcare quality, patient safety and value.
This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.
For Further Information
Constellation Asset Advisors, Inc.
Director of Communications
« back to news page